RELATIVE EFFICACY AND SAFETY OF TOFACITINIB, BARICITINIB, UPADACITINIB, AND FILGOTINIB, IN COMPARISON WITH ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0

作者：

Lee, Y. H. ^{[1
]}

Song, G. G. ^{[1
]}

机构：

[1] Korea Univ, Rheumatol, Seoul, South Korea

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.658

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0136

引用

页码：1001 / 1001

页数：1

共 50 条

[1] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
Lee, Young Ho
Song, Gwan Gyu
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 785 - 796
[2] Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Lee, Y. H.
Song, G. G.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (06): : 590 - 603
[3] Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Bae, S-C
Lee, Y. H.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 559 - 567
[4] Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Song, Gwan Gyu
Choi, Sung Jae
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (08) : 1563 - 1571
[5] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 751 - 751
[6] Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Lee, Young Ho
Song, Gwan Gyu
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 868 - 875
[7] Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Sung, Yoon-Kyoung
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (08) : 557 - 565
[8] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis; [Relative Wirksamkeit und Sicherheit von Tofacitinib, Baricitinib, Upadacitinib und Filgotinib im Vergleich zu Adalimumab bei Patienten mit aktiver rheumatoider Arthritis]
Lee Y.H.
Song G.G.
[J]. Zeitschrift für Rheumatologie, 2020, 79 (8) : 785 - 796
[9] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1275 - 1276
[10] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Gwan Gyu Song
Young Ho Lee
[J]. Clinical Drug Investigation, 2019, 39 : 421 - 428

← 1 2 3 4 5 →